Immediate Impact

3 from Science/Nature 58 standout
Sub-graph 1 of 22

Citing Papers

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2023 Standout
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
2023 Standout
1 intermediate paper

Works of C Bressot being referenced

Bacteremia in patients receiving TNF-alpha antagonists – A prospective multicenter study
2013

Author Peers

Author Last Decade Papers Cites
C Bressot 97 70 16 226 182 14 449
Ph. Bordier 59 64 3 161 142 11 445
C M Francucci 106 33 4 102 150 20 454
Panagiota Andreopoulou 26 109 219 116 10 459
Usha Sriram 103 25 164 188 12 421
Abigail Samuels 51 31 1 124 102 17 383
Paulo Gustavo Sampaio Lacativa 40 48 70 129 21 418
R. Neer 41 27 3 121 166 14 385
D.H. Cove 39 96 2 203 64 14 474
Katrine Hygum 137 15 119 253 10 464
N. Ota 46 29 1 91 124 21 449

All Works

Loading papers...

Rankless by CCL
2026